Torgerson Lance's Form 4 filing
Civeo CorpCVEO · filed Oct 21, 2021
- Accession no.
- 0000899243-21-040987
- Filed
- Oct 21, 2021, 5:33 PM ET
- Trade date
- Oct 19-21, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $383.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Torgerson LanceCIK 0001735901 | 10% Owner |
| Torgerson TammyCIK 0001736750 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2021 | Common Stock | SSaleDisposed | −4,933 | $22.81F1 | −$112,521.73 | 1,549,135 | Indirect | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −731 | $22.81F1 | −$16,674.11 | 464,800 | Indirect | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −4,899 | $22.46F3 | −$110,031.54 | 1,544,236 | Indirect | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −726 | $22.46F3 | −$16,305.96 | 464,074 | Indirect | |
| Oct 21, 2021 | Common Stock | SSaleDisposed | −4,905 | $22.69F4 | −$111,294.45 | 1,539,331 | Indirect | |
| Oct 21, 2021 | Common Stock | SSaleDisposed | −727 | $22.69F4 | −$16,495.63 | 463,347 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were sold in multiple trades pursuant to a 10b5-1 plan at prices ranging from $22.58 to $23.13. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.
- F3
The shares were sold in multiple trades pursuant to a 10b5-1 plan at prices ranging from $22.25 to $22.63. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.
- F4
The shares were sold in multiple trades pursuant to a 10b5-1 plan at prices ranging from $22.50 to $23.02. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.